Abstract

No data exist on hepatitis B virus (HBV) incidence among African men who have sex with men (MSM). We tested plasma samples archived between 2005 and 2014 for HBV core antibody or surface antigen seroconversion in a cohort of 312 initially human immunodeficiency virus (HIV)-1-negative MSM with no evidence of prior HBV infection. Hepatitis B virus incidence was 6.0/100 person-years (95% confidence interval [CI], 3.9–9.1). Hepatitis B virus acquisition was associated with being uncircumcised (adjusted incidence rate ratio [aIRR], 5.0; 95% CI, 1.5–16.8), recent HIV-1 acquisition (aIRR, 2.9; 95% CI, 1.1–7.7), rape (aIRR, 5.0; 95% CI, 1.2–20.4), and any tertiary education (aIRR, 3.2; 95% CI, 1.1–9.7). African MSM have a substantial risk of HBV acquisition and require vaccination urgently.

Highlights

  • Human immunodeficiency virus-1 incidence among men who have sex with men (MSM) in Kenya has been estimated at 8–10 per 100 person years [6, 7], with estimates as high as 35.2 per 100 person years among MSM only [7]

  • Because hepatitis B virus (HBV) is more infectious than human immunodeficiency virus (HIV)-1 [8], it may be expected that HBV incidence

  • In the multivariable analysis adjusted for age, marital status, sex work, Receptive anal intercourse (RAI), and any unprotected sex, uncircumcised status, recent human immunodeficiency virus (HIV-1) acquisition, rape (5.0; 95% confidence interval (CI) 1.2–20.4) and any tertiary education were associated with HBV acquisition (Table 2)

Read more

Summary

METHODS

We retrospectively tested stored plasma samples from HIV-1negative MSM aged 18–49 years who were enrolled into a HIV-1 vaccine feasibility cohort study between 2005 and 2014 in Coastal Kenya [7]. All male cohort participants who reported anal sex with another man in the 3 months before enrollment and had stored blood samples available from enrollment and at least 1 follow-up visit through December 2014 were selected for the present study

Cohort Procedures
Laboratory Methods
RESULTS
DISCUSSION
CONCLUSIONS
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.